We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Amazon Launches Connected Medical Device Brand

By HospiMedica International staff writers
Posted on 05 Nov 2018
Print article
Image: The Choice wireless blood glucose monitor (Photo courtesy of Amazon).
Image: The Choice wireless blood glucose monitor (Photo courtesy of Amazon).
Amazon (Seattle, WA, USA) has launched an exclusive line of consumer-use medical devices focused on helping consumers manage their diabetes or cardiovascular conditions.

The online retail leader partnered with the Arcadia Group (Atlanta, GA, USA) to launch the Choice product line, composed of blood glucose and blood pressure monitors sold directly to consumers, with both standard and Bluetooth-enabled models offered. The Choice wireless blood glucose monitor, which costs just USD 23 on the Amazon website, is a tiny, stylish device that provides accurate results in just five seconds. A more basic model is available, without wireless compatibility, for USD 11.

The Choice wireless blood glucose monitor includes the monitor, a lancing device, 10 lancets, a carrying case, a quick start guide and owner's manual, and pre-installed batteries. The device wirelessly transmits data to a smartphone through the free Amazon diabetes management app, called AgaMatrix Diabetes Manager, compatible with both iOS and Android devices, which stores, manages, and shares diabetes information with healthcare providers. No prescriptions or insurance required. The monitor works only with Choice brand test strips, sold separately.

The Choice wireless blood pressure monitor is offered in three versions. An upper arm version provides easy one-button operation with expanded smartphone support. The device wirelessly connects to the free Choice blood pressure app, which displays readings, graphs, and tips on managing hypertension. The cuff fits most arm diameters, providing gentle inflation for a more comfortable experience; a multi-user model that can monitor up to four people is also available. Two basic models are available without Bluetooth connectivity, an upper arm version and a wrist version.

“Consumers no longer need to drive to a store to stand in-line and purchase their medical devices and supplies. Now, in the privacy of their home, consumers can review, compare, and purchase the products of their choice The Choice brand is all about accessible wellness,” said Bob Guest, CEO of the Arcadia Group. “No insurance is required; therefore, customers have the freedom of choice. They will no longer be told by their insurance company what brand they can buy. Choice is freedom.”

The Choice line is a private label of the Arcadia Group, which will be sold only on Amazon. The Arcadia group has also developed similar health brands for Walmart and other companies.

Related Links:
Arcadia Group
Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Patient Management System
Digital Physician's Model
Mammography Illuminator

Print article



view channel
Image: The WHO has conditionally recommended the use of algorithms in assisting with pediatric tuberculosis diagnosis (Photo courtesy of Pexels)

New Evidence-Based Algorithms Could Improve Diagnosis of Pediatric Tuberculosis

Tuberculosis (TB) continues to be one of the most prevalent causes of death among younger populations worldwide. Research indicates that over 96% of the deadly TB cases in children under the age of 15... Read more

Surgical Techniques

view channel
Image: Lighting up tumors could help surgeons remove them more precisely (Photo courtesy of Pexels)

‘Molecular Imaging’ Lights up Tumors for Surgeons to Enable Precise Removal

Neuroblastoma is a devastating form of childhood cancer that accounts for 8-10% of all childhood cancers and roughly 15% of all childhood deaths from cancer. Sadly, in almost one-third of cases, the cancer... Read more


view channel
Image: The demand for endometrial ablation devices is increasing due to rising prevalence of gynecological disorders (Photo courtesy of Pexels)

Global Endometrial Ablation Market Driven by Rising Prevalence of Gynecological Disorders

Gynecological disorders, such as menorrhagia, PCOD, abnormal vaginal bleeding, affect millions of women globally every year and are on the rise. Abnormal Uterine Bleeding (AUB) is the most common disorder... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.